Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease

NCT02339415 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.

NCT NCT02339415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02339415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease
Lead sponsor
Hennepin Healthcare Research Institute
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
September 30, 2018
Enrollment
44 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation, hiv infection, inflammation